What is CyberMDX?
Founded in 2016 and headquartered in New York, CyberMDX operates at the intersection of medical technology and cybersecurity. The firm specializes in the identification, categorization, and protection of connected medical devices, a sector that has become increasingly vulnerable as hospitals undergo rapid digital transformation. By providing visibility into clinical networks, CyberMDX ensures operational resiliency, patient safety, and stringent data privacy compliance. Its market position is defined by its ability to mitigate risks associated with the Internet of Medical Things (IoMT), providing healthcare providers with the tools necessary to maintain secure and reliable patient care environments.
How much funding has CyberMDX raised?
CyberMDX has raised a total of $30M across 2 funding rounds:
Series A
$10M
Other Financing Round
$20M
Series A (2018): $10M, investors not publicly disclosed
Other Financing Round (2020): $20M led by Qure Ventures, Pitango Venture Capita, and Relyens Group
Key Investors in CyberMDX
Qure Ventures
A venture capital firm focused on early-stage digital health and medical technology investments.
Pitango Venture Capital
A prominent venture capital group that invests in high-growth technology companies across various sectors.
Relyens Group
A European mutual group specializing in risk management and insurance solutions for healthcare and local government sectors.
What's next for CyberMDX?
With the recent influx of capital, CyberMDX is well-positioned to accelerate its product development roadmap and expand its footprint in the enterprise healthcare market. The strategic focus will likely shift toward enhancing its threat detection algorithms and deepening integration capabilities with existing hospital information systems. As the regulatory environment for medical device security tightens, the company's ability to provide automated, real-time protection will be a key differentiator. Future growth will depend on its capacity to maintain its technological edge while scaling its sales and support infrastructure to meet the global demand for robust, specialized cybersecurity solutions in clinical settings.
See full CyberMDX company page
